176 related articles for article (PubMed ID: 21089003)
1. Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?
Ashtiani ZO; Hasheminasab SM; Ayati M; Goulian BS; Modarressi MH
Pathol Oncol Res; 2011 Jun; 17(2):269-75. PubMed ID: 21089003
[TBL] [Abstract][Full Text] [Related]
2. Null genotypes at the GSTM1 and GSTT1 genes and the risk of benign prostatic hyperplasia: a case-control study and a meta-analysis.
Choubey VK; Sankhwar SN; Tewari R; Sankhwar P; Singh BP; Rajender S
Prostate; 2013 Jan; 73(2):146-52. PubMed ID: 22692893
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.
Tan JSJ; Ong KC; Ong DBL; Wu YS; Razack A; Kuppusamy S; Lim J; Rhodes A
Malays J Pathol; 2019 Dec; 41(3):243-251. PubMed ID: 31901908
[TBL] [Abstract][Full Text] [Related]
5. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
Safarinejad MR; Shafiei N; Safarinejad SH
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
[TBL] [Abstract][Full Text] [Related]
7. GSTM1 and GSTT1 Polymorphisms and Susceptibility to Prostate Cancer: A Case-Control Study of the Algerian Population.
Benabdelkrim M; Djeffal O; Berredjem H
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2853-2858. PubMed ID: 30362312
[TBL] [Abstract][Full Text] [Related]
8. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
10. Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot study.
Kumar V; Yadav CS; Datta SK; Singh S; Ahmed RS; Goel S; Gupta S; Mustafa M; Grover RK; Banerjee BD
Dis Markers; 2011; 30(4):163-9. PubMed ID: 21694442
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
Binnie MC; Alexander FE; Heald C; Habib FK
Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from North India.
Mittal RD; Srivastava DS; Mandhani A; Kumar A; Mittal B
Indian J Cancer; 2004; 41(3):115-9. PubMed ID: 15472409
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
15. The place of androgen receptor gene mutation analysis in the molecular diagnosis of prostate cancer and genotype-phenotype relationship.
Kizilay F; Kalemci MS; Şimşir A; Turna B; Nazli O; Berdeli A
Turk J Med Sci; 2014; 44(2):261-6. PubMed ID: 25536734
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population.
Silig Y; Pinarbasi H; Günes S; Ayan S; Bagci H; Cetinkaya O
Cancer Invest; 2006 Feb; 24(1):41-5. PubMed ID: 16466991
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India.
Srivastava DS; Mandhani A; Mittal B; Mittal RD
BJU Int; 2005 Jan; 95(1):170-3. PubMed ID: 15638917
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population.
Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
Asian Pac J Cancer Prev; 2010; 11(4):1067-72. PubMed ID: 21133626
[TBL] [Abstract][Full Text] [Related]
20. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]